Clinical Trial Update: Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluates tislelizumab in combination with chemotherapy and thoracic radiotherapy for extensive-stage small-cell lung cancer; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Second Hospital of Shanxi Medical University | Conditions: Extensive-stage Small-cell Lung Cancer | Phase 2 | Status: RECRUITING